Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 207

Similar articles for PubMed (Select 23111194)

1.

CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.

Bradly DP, Gattuso P, Pool M, Basu S, Liptay M, Bonomi P, Buckingham L.

Diagn Mol Pathol. 2012 Dec;21(4):207-13. doi: 10.1097/PDM.0b013e31825554b2.

PMID:
23111194
2.

PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.

Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, Fidler M, Walters K, Bonomi P, Coon J.

Int J Cancer. 2010 Apr 1;126(7):1630-9. doi: 10.1002/ijc.24896.

PMID:
19795445
3.

A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas.

Sterlacci W, Tzankov A, Veits L, Zelger B, Bihl MP, Foerster A, Augustin F, Fiegl M, Savic S.

J Thorac Oncol. 2011 Oct;6(10):1649-57. doi: 10.1097/JTO.0b013e3182295745.

PMID:
21857254
4.

Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.

Yoshino M, Suzuki M, Tian L, Moriya Y, Hoshino H, Okamoto T, Yoshida S, Shibuya K, Yoshino I.

Int J Oncol. 2009 Nov;35(5):1201-9.

PMID:
19787276
5.

Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.

Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.

Int J Oncol. 2001 Aug;19(2):277-81.

PMID:
11445839
6.

p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.

Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.

Clin Cancer Res. 2002 Dec;8(12):3782-7.

7.

Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.

Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV.

Oncogene. 2001 Jun 14;20(27):3528-32.

8.

Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.

Lung Cancer. 2007 Oct;58(1):131-8. Epub 2007 Jul 2.

PMID:
17606310
10.

Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.

Ota N, Kawakami K, Okuda T, Takehara A, Hiranuma C, Oyama K, Ota Y, Oda M, Watanabe G.

Anticancer Res. 2006 Sep-Oct;26(5B):3729-32.

11.
12.

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.

Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.

Carcinogenesis. 2004 Nov;25(11):2165-71. Epub 2004 Jul 1.

13.

Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K.

Int J Cancer. 2003 Oct 10;106(6):913-8.

PMID:
12918069
14.
15.

p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.

Su PF, Huang WL, Wu HT, Wu CH, Liu TY, Kao SY.

Oral Oncol. 2010 Oct;46(10):734-9. doi: 10.1016/j.oraloncology.2010.07.002. Epub 2010 Aug 21.

PMID:
20729138
16.

Aberrant promoter hypermethylation in serum DNA from patients with silicosis.

Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.

Carcinogenesis. 2008 Sep;29(9):1845-9. doi: 10.1093/carcin/bgn169. Epub 2008 Jul 16.

17.

p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos.

Andujar P, Wang J, Descatha A, Galateau-Sallé F, Abd-Alsamad I, Billon-Galland MA, Blons H, Clin B, Danel C, Housset B, Laurent-Puig P, Le Pimpec-Barthes F, Letourneux M, Monnet I, Régnard JF, Renier A, Zucman-Rossi J, Pairon JC, Jaurand MC.

Lung Cancer. 2010 Jan;67(1):23-30. doi: 10.1016/j.lungcan.2009.03.018. Epub .

PMID:
19375815
18.

p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.

Cancer Res. 2001 Apr 15;61(8):3419-24.

19.

Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.

Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T.

Clin Cancer Res. 2010 Apr 15;16(8):2418-26. doi: 10.1158/1078-0432.CCR-09-2819. Epub 2010 Apr 6.

20.

DNA methylation markers and early recurrence in stage I lung cancer.

Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG.

N Engl J Med. 2008 Mar 13;358(11):1118-28. doi: 10.1056/NEJMoa0706550.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk